Analysis Group (HEOR, Epidemiology & Market Access)
Overview
One of the largest economics consulting firms (founded 1981), with a dedicated HEOR, epidemiology, and market access practice supporting pharmaceutical products throughout their lifecycles with economic modeling and evidence strategy.
Notable
1,500+ professionals across 15 offices in North America, Europe, and Asia.
Key services
- HEOR strategy & studies
- Cost-effectiveness & budget impact models
- Epidemiology & biostatistics
- Value evidence for payers
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Analysis Group (HEOR, Epidemiology & Market Access)? Share your experience in a short, confidential interview.
Share your experience